Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Assets Average (2009 - 2025)

Grifols' (GIFLF) quarterly Assets Average came in at $22.9 billion in Q4 2025, up 0.79% on a YoY basis from $22.7 billion in Q4 2024, and up 0.79% quarter-over-quarter from $22.7 billion in Q4 2024.

Analysis

Grifols (GIFLF) Assets Average (2009 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Assets Average for 16 consecutive years, with $22.9 billion the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Assets Average rose 0.79% year-over-year to $22.9 billion; the trailing twelve-month figure through Dec 2025 stood at $22.9 billion (up 0.79% YoY), and the FY2025 full-year result was $11.2 billion, up 7520.64% from the prior year.
  • Assets Average advanced to $22.9 billion in Q4 2025 per GIFLF's latest filing, from $22.7 billion in the prior quarter.
  • Across five years, Assets Average topped out at $22.9 billion in Q4 2025 and bottomed at $13.3 billion in Q4 2021.
  • Historically, Assets Average has averaged $19.2 billion across 5 years, with a median of $22.1 billion in 2023.
  • The sharpest annual moves came in 2021 and 2023: Assets Average declined 27.15% in 2021, then jumped 47.34% in 2023.
  • Over 5 years, Assets Average stood at $13.3 billion in 2021, then rose by 12.97% to $15.0 billion in 2022, then surged by 47.34% to $22.1 billion in 2023, then grew by 2.74% to $22.7 billion in 2024, then advanced by 0.79% to $22.9 billion in 2025.
  • According to Business Quant data, Assets Average over the past three periods registered $22.9 billion, $22.7 billion, and $22.1 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn 94.07 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn 52.82 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn 26.95 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn 41.30 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn -
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn 11.22 Bn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn 5.34 Bn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn 30.78 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn 5.51 Bn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn 22.91 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 22.91 Bn
Dec 31, 2024 22.73 Bn
Dec 31, 2023 22.12 Bn
Dec 31, 2022 15.01 Bn
Dec 31, 2021 13.29 Bn
Dec 31, 2020 18.24 Bn
Sep 30, 2020 17.91 Bn
Mar 31, 2020 17.38 Bn
Dec 31, 2019 16.41 Bn
Sep 30, 2019 15.42 Bn
Mar 31, 2019 14.73 Bn
Dec 31, 2018 13.97 Bn
Sep 30, 2018 13.67 Bn
Jun 30, 2018 15.05 Bn
Mar 31, 2018 14.65 Bn
Dec 31, 2017 12.54 Bn
Dec 31, 2016 10.81 Bn
Sep 30, 2016 10.73 Bn
Jun 30, 2016 10.48 Bn
Mar 31, 2016 10.36 Bn